{"database": "lobbying", "table": "lobbying_activities", "rows": [[1805750, "0c0f62cd-cd75-444c-8d4a-81488de07248", "Q1", "PHARMAVITE LLC", 286074, "PHARMAVITE LLC", 2016, "first_quarter", "FOO", "*Adequate FDA resources to implement GMP rules for dietary supplements and to provide adequate funds for full inspection of dietary supplement manufacturers.\n*Support for prompt publication of NDI Guidance from FDA\n*Full implementation of DASCA (HR 4771/S2012)", "HOUSE OF REPRESENTATIVES,SENATE", 0, 0, "2016-04-12T17:47:33.690000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1805750"], "units": {}, "query_ms": 0.3577600000426173, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}